Showing results (1691-1700 of 4,124) with videos related to
Sort By:
Pageof 413
Human Gene Therapy|November 7, 2008
Clinical responses to gene therapy in joints of two subjects with rheumatoid arthritisPeter Wehling, Julio Reinecke, Axel W A Baltzer, et al.Human Gene Therapy|April 15, 2009
Persistence of high-capacity adenoviral vectors as replication-defective monomeric genomes in vitro and in murine liverLorenz Jager, Anja EhrhardtHuman Gene Therapy|February 10, 2009
Foamy and lentiviral vectors transduce canine long-term repopulating cells at similar efficiencyGrant D Trobridge, James Allen, Laura Peterson, et al.Human Gene Therapy|February 10, 2009
Adenovirus encoding human platelet-derived growth factor-B delivered to alveolar bone defects exhibits safety and biodistribution profiles favorable for clinical usePo-Chun Chang, Joni A Cirelli, Qiming Jin, et al.Human Gene Therapy|February 11, 2009
A sensitive cell-based assay to measure the doxycycline concentration in biological samplesWendy Kleibeuker, Xue Zhou, Mireille Centlivre, et al.Human Gene Therapy|February 14, 2009
A multi-DNA preventive vaccine for p53/Neu-driven cancer syndromeC De Giovanni, G Nicoletti, A Palladini, et al.Human Gene Therapy|August 23, 2008
In vivo delivery of bionanocapsules displaying Phaseolus vulgaris agglutinin-L4 isolectin to malignant tumors overexpressing N-acetylglucosaminyltransferase VTakeshi Kasuya, Joohee Jung, Hiroyasu Kadoya, et al.Human Gene Therapy|September 2, 2008
Internal radiotherapy of liver cancer with rat hepatocarcinoma-intestine-pancreas gene as a liver tumor-specific promoterJulie Hervé, Antonio Sa Cunha, Bingkai Liu, et al.Human Gene Therapy|August 30, 2008
Novel oncolytic agent GLV-1h68 is effective against malignant pleural mesotheliomaKaitlyn J Kelly, Yanghee Woo, Peter Brader, et al.Human Gene Therapy|September 14, 2007
Prolonged in vivo gene silencing by electroporation-mediated plasmid delivery of small interfering RNADaniël Eefting, Jos M Grimbergen, Margreet R de Vries, et al.Pageof 413